Home Cart 0 Sign in  
X

[ CAS No. 99-11-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 99-11-6
Chemical Structure| 99-11-6
Chemical Structure| 99-11-6
Structure of 99-11-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 99-11-6 ]

Related Doc. of [ 99-11-6 ]

Alternatived Products of [ 99-11-6 ]

Product Details of [ 99-11-6 ]

CAS No. :99-11-6 MDL No. :MFCD00006274
Formula : C6H5NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :CSGQJHQYWJLPKY-UHFFFAOYSA-N
M.W : 155.11 Pubchem ID :7425
Synonyms :
Chemical Name :6-Hydroxy-2-oxo-1,2-dihydropyridine-4-carboxylic acid

Calculated chemistry of [ 99-11-6 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 3.0
Molar Refractivity : 36.05
TPSA : 90.39 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.74 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.34
Log Po/w (XLOGP3) : -0.69
Log Po/w (WLOGP) : -0.22
Log Po/w (MLOGP) : -0.31
Log Po/w (SILICOS-IT) : 0.43
Consensus Log Po/w : -0.09

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -0.7
Solubility : 30.6 mg/ml ; 0.197 mol/l
Class : Very soluble
Log S (Ali) : -0.73
Solubility : 28.7 mg/ml ; 0.185 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.72
Solubility : 29.8 mg/ml ; 0.192 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.73

Safety of [ 99-11-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 99-11-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 99-11-6 ]
  • Downstream synthetic route of [ 99-11-6 ]

[ 99-11-6 ] Synthesis Path-Upstream   1~37

  • 1
  • [ 99-11-6 ]
  • [ 42521-08-4 ]
Reference: [1] Organic Letters, 2001, vol. 3, # 26, p. 4263 - 4265
[2] Organic Letters, 2003, vol. 5, # 7, p. 967 - 970
[3] Patent: WO2004/46103, 2004, A2, . Location in patent: Page 33-34
[4] Arkivoc, 2011, vol. 2011, # 6, p. 92 - 119
[5] ChemMedChem, 2013, vol. 8, # 6, p. 967 - 975
  • 2
  • [ 99-11-6 ]
  • [ 6457-49-4 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1938, vol. <2> 151, p. 65,79
  • 3
  • [ 99-11-6 ]
  • [ 113293-70-2 ]
Reference: [1] Chemical Communications, 1998, # 15, p. 1567 - 1568
[2] Patent: WO2012/97682, 2012, A1,
  • 4
  • [ 99-11-6 ]
  • [ 39965-81-6 ]
Reference: [1] Patent: US2011/46170, 2011, A1,
[2] Patent: WO2009/109907, 2009, A1,
  • 5
  • [ 99-11-6 ]
  • [ 2587-02-2 ]
Reference: [1] ChemMedChem, 2013, vol. 8, # 6, p. 967 - 975
  • 6
  • [ 55-22-1 ]
  • [ 22282-72-0 ]
  • [ 99-11-6 ]
Reference: [1] Patent: EP1801102, 2007, A1, . Location in patent: Page/Page column 9-10
[2] Patent: EP1801102, 2007, A1, . Location in patent: Page/Page column 9-10
[3] Patent: EP1801102, 2007, A1, . Location in patent: Page/Page column 9-10
  • 7
  • [ 99-11-6 ]
  • [ 101990-69-6 ]
Reference: [1] Tetrahedron, 2007, vol. 63, # 2, p. 291 - 298
[2] Journal of the American Chemical Society, 2005, vol. 127, # 29, p. 10124 - 10125
[3] Chemical Communications, 1998, # 15, p. 1567 - 1568
[4] Journal fuer Praktische Chemie (Leipzig), 1938, vol. <2> 151, p. 65,79
[5] Patent: WO2012/97682, 2012, A1,
  • 8
  • [ 99-11-6 ]
  • [ 15855-06-8 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 34, p. 6951 - 6963
[2] Organic Letters, 2000, vol. 2, # 22, p. 3421 - 3423
[3] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 5, p. 1429 - 1433
  • 9
  • [ 99-11-6 ]
  • [ 75-57-0 ]
  • [ 42521-09-5 ]
Reference: [1] Organic Letters, 2003, vol. 5, # 7, p. 967 - 970
[2] Journal of the American Chemical Society, 2005, vol. 127, # 29, p. 10124 - 10125
[3] ChemMedChem, 2013, vol. 8, # 6, p. 967 - 975
[4] Organic Letters, 2008, vol. 10, # 19, p. 4383 - 4386
[5] Arkivoc, 2011, vol. 2011, # 6, p. 92 - 119
  • 10
  • [ 67-56-1 ]
  • [ 99-11-6 ]
  • [ 42521-09-5 ]
Reference: [1] Dalton Transactions, 2017, vol. 46, # 12, p. 4075 - 4085
[2] Synthesis, 2008, # 17, p. 2764 - 2770
  • 11
  • [ 99-11-6 ]
  • [ 42521-09-5 ]
Reference: [1] Tetrahedron, 2007, vol. 63, # 2, p. 291 - 298
[2] Chemical Communications, 2015, vol. 51, # 74, p. 14123 - 14126
  • 12
  • [ 99-11-6 ]
  • [ 42521-09-5 ]
Reference: [1] ChemMedChem, 2015, vol. 10, # 1, p. 116 - 133
  • 13
  • [ 99-11-6 ]
  • [ 1604-14-4 ]
Reference: [1] Patent: WO2012/97682, 2012, A1,
[2] Research on Chemical Intermediates, 2014, vol. 40, # 3, p. 1147 - 1155
  • 14
  • [ 77-92-9 ]
  • [ 99-11-6 ]
YieldReaction ConditionsOperation in experiment
85.18% With urea In water at 185℃; for 2 h; Sonication; High pressure (1) Take 1.2188 g (0.0058 mol) of citric acid and 1.3932 g (0.0231 mol) of urea dissolved in 60 ml of deionized water, sonicate for 10 min, and mix well; (2) The mixture is charged into the reaction vessel, the oven temperature is set to 185 ° C, and the temperature is kept under hydrothermal conditions for 2 h; Cooling to room temperature to obtain a dark green solution; (3) The solution was placed in a constant temperature water bath at 60 ° C, magnetically stirred, and 98percent sulfuric acid was added dropwise to the solution until the pH of the solution was 2-3. A large amount of yellow solid precipitate was observed and centrifuged at 12000 r/min for 10 min. Remove the supernatant, wash it with deionized water multiple times, and drain it. The obtained yellow precipitate was dried in an oven at 60 ° C to obtain 85.18percent of the citrazinic acid product.
Reference: [1] Patent: CN108164458, 2018, A, . Location in patent: Paragraph 0010; 0012; 0013
[2] Journal of the American Pharmaceutical Association (1912-1977), 1956, vol. 45, p. 478
  • 15
  • [ 55-22-1 ]
  • [ 22282-72-0 ]
  • [ 99-11-6 ]
Reference: [1] Patent: EP1801102, 2007, A1, . Location in patent: Page/Page column 9-10
[2] Patent: EP1801102, 2007, A1, . Location in patent: Page/Page column 9-10
[3] Patent: EP1801102, 2007, A1, . Location in patent: Page/Page column 9-10
  • 16
  • [ 597-59-1 ]
  • [ 99-11-6 ]
Reference: [1] Chemische Berichte, 1884, vol. 17, p. 2688
[2] Patent: DE957033, 1952, ,
[3] Journal of the Chemical Society, 1892, vol. 61, p. 1009
  • 17
  • [ 725679-43-6 ]
  • [ 99-11-6 ]
Reference: [1] Chemische Berichte, 1884, vol. 17, p. 2688
[2] Journal of the Chemical Society, 1892, vol. 61, p. 1009
  • 18
  • [ 130839-31-5 ]
  • [ 99-11-6 ]
Reference: [1] Chemische Berichte, 1884, vol. 17, p. 2688
[2] Journal of the Chemical Society, 1892, vol. 61, p. 1009
  • 19
  • [ 5398-44-7 ]
  • [ 99-11-6 ]
Reference: [1] Journal of the Chemical Society, 1897, vol. 71, p. 1082[2] Journal of the Chemical Society, 1898, vol. 73, p. 441
  • 20
  • [ 1587-20-8 ]
  • [ 99-11-6 ]
Reference: [1] Journal of the Chemical Society, 1892, vol. 61, p. 1009
[2] Chemische Berichte, 1884, vol. 17, p. 2688
[3] Cesko-Slovenska Farmacie, 1957, vol. 6, p. 369,370[4] Chem.Abstr., 1958, p. 10071
  • 21
  • [ 57-13-6 ]
  • [ 77-92-9 ]
  • [ 99-11-6 ]
Reference: [1] Patent: DE1011885, 1954, ,
  • 22
  • [ 99-11-6 ]
  • [ 5398-44-7 ]
YieldReaction ConditionsOperation in experiment
89% at 130 - 145℃; for 20 h; Citrazinic acid (10.35 g, 66.7 mmol) and tetraethylammonium chloride (11.05 g, 66.7 mmol) were suspended in phosphoroxychloride (20 mL, excess) and heated at 130 °C for 18 h and then at 145 °C for 2 h. The reaction mixture was allowed to cool to RT and poured onto crushed ice (150 g). Extraction of ethyl acetate (3 x 100 mL), drying of the combined organic layers (MGS04) and evaporation in vacuo gave 11. 34 g (89 percent) of a white solid. IH NMR (400 MHz, DMSO-d6) 8 7.85 (s, 2H) 13.90 (br s, OH).
81%
Stage #1: at 140℃; for 24 h;
Stage #2: at 0℃; for 2 h;
Citrazinic acid 1 (20.0 g, 129 mmol) and benzyltriethylammonium chloride (32.3 g, 142 mmol) in 40 ml of POCl3 were heated to 140 °C for 24 h under a CaCl2 drying tube. After being cooled to room temperature, the brown mixture was poured on ice (400 g) and stirred for 2 h. The resulting brown solid was filtered off, washed with water and dissolved in EtOAc (400 ml). The organic phase was then washed with saturated NH4Cl, dried over Na2SO4 and evaporated to dryness to afford 20 g (81percent) of the desired compound as a brown solid. 1H and 13C NMR were in accordance with those already reported.18
Reference: [1] Chemical Communications, 2015, vol. 51, # 74, p. 14123 - 14126
[2] Patent: WO2004/63156, 2004, A1, . Location in patent: Page 35
[3] Tetrahedron Letters, 2011, vol. 52, # 5, p. 584 - 587
[4] Journal of Organic Chemistry, 1997, vol. 62, # 19, p. 6588 - 6597
[5] Chemical Communications, 1998, # 15, p. 1567 - 1568
[6] Tetrahedron, 2007, vol. 63, # 2, p. 291 - 298
[7] Tetrahedron, 2002, vol. 58, # 34, p. 6951 - 6963
[8] Organic Letters, 2000, vol. 2, # 22, p. 3421 - 3423
[9] Journal of the American Pharmaceutical Association (1912-1977), 1956, vol. 45, p. 478

[10] Yakugaku Zasshi, 1953, vol. 73, p. 969[11] Chem.Abstr., 1954, p. 11420
[12] Journal fuer Praktische Chemie (Leipzig), 1938, vol. <2> 151, p. 65,79
[13] Journal of Agricultural and Food Chemistry, 2005, vol. 53, # 25, p. 9775 - 9780
[14] Journal of the American Chemical Society, 2005, vol. 127, # 29, p. 10124 - 10125
[15] Organic Letters, 2003, vol. 5, # 7, p. 967 - 970
[16] Monatshefte fur Chemie, 2008, vol. 139, # 12, p. 1491 - 1498
[17] Monatshefte fur Chemie, 2008, vol. 139, # 11, p. 1409 - 1415
[18] Organic Letters, 2010, vol. 12, # 5, p. 940 - 943
[19] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 5, p. 1429 - 1433
[20] Patent: WO2012/97682, 2012, A1, . Location in patent: Page/Page column 66
[21] Patent: WO2012/97479, 2012, A1, . Location in patent: Page/Page column 138
[22] Patent: WO2012/97683, 2012, A1, . Location in patent: Page/Page column 72-73
[23] ChemMedChem, 2013, vol. 8, # 6, p. 967 - 975
[24] Research on Chemical Intermediates, 2014, vol. 40, # 3, p. 1147 - 1155
[25] Patent: US2014/171429, 2014, A1, . Location in patent: Paragraph 0312
  • 23
  • [ 99-11-6 ]
  • [ 5398-44-7 ]
Reference: [1] ChemMedChem, 2015, vol. 10, # 1, p. 116 - 133
  • 24
  • [ 824-72-6 ]
  • [ 99-11-6 ]
  • [ 5398-44-7 ]
Reference: [1] Journal of the American Chemical Society, 1958, vol. 80, p. 5481
  • 25
  • [ 99-11-6 ]
  • [ 10025-87-3 ]
  • [ 5398-44-7 ]
Reference: [1] Chemische Berichte, 1902, vol. 35, p. 2933
  • 26
  • [ 99-11-6 ]
  • [ 2016-99-1 ]
YieldReaction ConditionsOperation in experiment
64%
Stage #1: at 180℃; for 3 h;
Stage #2: at 0℃;
Example 15; Synthesis of 2, 6-Dibromoisonicotinic Acid; [0114] Citrazinic acid (2.33 g, 0.015 moles) and phosphorous oxybromide were combined and heated to 180 °C under a nitrogen atmosphere for three hours. The cooled reaction was carefully quenched with ice-water. The mixture was filtered and the aqueous portion extracted with dichloromethane (4 x 40 ml). The solids were extracted in a Soxhlet extractor with dichloromethane for twelve hours. The organic portion from the direct extraction was dried over sodium sulfate, filtered, and stripped to give 2.2 g of reddish solid. The organic portion from the Soxhlet extraction was dried over sodium sulfate, filtered, and stripped to give 0.5 g of reddish solid. The two portions of 2,6- dibromoisonicotinic acid (64 percent yield) were similar by NMR and were combined.'H NMR (CDC13) 8. 04 (2H, s).
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 12, p. 5079 - 5093
[2] Tetrahedron, 2007, vol. 63, # 2, p. 291 - 298
[3] Organic and Biomolecular Chemistry, 2005, vol. 3, # 8, p. 1460 - 1467
[4] Patent: WO2005/84439, 2005, A1, . Location in patent: Page/Page column 35
[5] Synthesis, 2000, # 8, p. 1138 - 1142
[6] Yakugaku Zasshi, 1953, vol. 73, p. 969[7] Chem.Abstr., 1954, p. 11420
[8] Tetrahedron Letters, 2001, vol. 42, # 35, p. 6113 - 6115
[9] Journal of Organic Chemistry, 2006, vol. 71, # 12, p. 4696 - 4699
[10] Chemical Communications, 2009, # 16, p. 2121 - 2123
  • 27
  • [ 99-11-6 ]
  • [ 2897-43-0 ]
Reference: [1] ChemMedChem, 2013, vol. 8, # 6, p. 967 - 975
  • 28
  • [ 99-11-6 ]
  • [ 97682-44-5 ]
Reference: [1] Journal of Organic Chemistry, 1997, vol. 62, # 19, p. 6588 - 6597
  • 29
  • [ 67-56-1 ]
  • [ 99-11-6 ]
  • [ 119308-57-5 ]
YieldReaction ConditionsOperation in experiment
79%
Stage #1: at 130℃;
Stage #2: at 0℃;
A mixture of citrazinic acid (5.0 g, 32.2 mmol) and POBr3 (27.5 g, 96.8 mmol) is heated at 130 0C. Upon completion of the reaction, the thick slurry is cooled to 0 0C and the reaction is carefully quenched with MeOH (250 ml_). The reaction mixture is concentrated in vacuo and then extracted between dichloromethane and sat. aq. NaHCO3. Organic layer is dried over anhydrous Na2SO4 and concentrated in vacuo to give a tan solid that is clean enough by NMR/LCMS to use further (7.5 g, 79percent). (ESI) m/z 295.8 (M+1 ). 1H NMR (400 MHz, CD2CI2) δ ppm 8.10 (s, 2 H), 4.05 (s, 3 H).
50%
Stage #1: at 185℃; for 8 h; Inert atmosphere
Stage #2: at 20℃; Reflux
The compound PBr3 (21.8 ml, 0.232 mol) was loaded into a 250 ml three -neck flask cooled in a room temperature water bath under a flow of nitrogen. Br 2 (11.9 ml, 0.231 mol) was then added dropwise with stirring to PBr 3 to yield a yellow solid (PBr5). 30 minutes was taken for addition of Br 2. P2O5 (12.0 g, 0.083 mol) was then <n="64"/>added and the solid mixture was mixed well with a spatula under a flow of nitrogen. A reflux condenser was added via a connection to a water -filled bubbler, to trap evolved HBr. The mixture was heated to 98 0C for 2 hours and then cooled to room temperature. Citrazinic acid (20.0 g, 0.128 mol) was then added and the solid was mixed thoroughly with a spatula under a flow of nitrogen. The mixture was heated at 1850C for 8 hours. The mixture was cooled back to room temperature. Methanol (150 ml) was slowly added (the reaction with methanol was exothermic, causing the solution to reflux). After the addition of methanol, the mixture was stirred until room temperature. Solid NaHCO3 was added slowly until bubbling stopped. After which, water (300 ml) was added and then additional NaHCO 3 was added until the bubbling stopped. A brown solid product was collected with filtration. The solid was washed with water and dried at room temperature under air. The product was purified by silica gel column using hexanes/ethyl acetate (9: 1) as a solvent. The final pure white product was obtained by recrystallization from methanol/water: 19.02 g (50.0percent).1H NMR (CDCl 3): δ 8.00 (s, 2H), 3.97 (s, 3H). 13C NMR (CDCl3): δ 162.74, 141.35, 141.25, 126.56, 53.38. MS (EI) m/z (percent): 294.8 (100percent) [M +].
Reference: [1] Journal of Medicinal Chemistry, 2010, vol. 53, # 15, p. 5422 - 5438
[2] Patent: WO2009/150230, 2009, A1, . Location in patent: Page/Page column 65
[3] European Journal of Inorganic Chemistry, 2010, # 13, p. 1913 - 1928
[4] Journal of Organic Chemistry, 2006, vol. 71, # 12, p. 4696 - 4699
[5] Synthesis, 2008, # 17, p. 2764 - 2770
[6] Patent: WO2009/80799, 2009, A2, . Location in patent: Page/Page column 62-63
[7] Patent: US2010/261687, 2010, A1, . Location in patent: Page/Page column 61
[8] Dalton Transactions, 2010, vol. 39, # 41, p. 9872 - 9878
[9] Chemical Communications, 2012, vol. 48, # 21, p. 2704 - 2706
[10] Patent: WO2012/45803, 2012, A1, . Location in patent: Page/Page column 25
[11] Patent: US2012/264729, 2012, A1, . Location in patent: Page/Page column 9
[12] ACS Medicinal Chemistry Letters, 2013, vol. 4, # 6, p. 542 - 546
[13] Journal of Medicinal Chemistry, 2014, vol. 57, # 20, p. 8307 - 8318
[14] Journal of Medicinal Chemistry, 2016, vol. 59, # 23, p. 10719 - 10737
[15] Organic Process Research and Development, 2017, vol. 21, # 2, p. 231 - 240
  • 30
  • [ 99-11-6 ]
  • [ 119308-57-5 ]
Reference: [1] Patent: US2010/331509, 2010, A1,
  • 31
  • [ 99-11-6 ]
  • [ 148332-36-9 ]
Reference: [1] Synthesis, 2000, # 8, p. 1138 - 1142
  • 32
  • [ 99-11-6 ]
  • [ 193001-91-1 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 34, p. 6951 - 6963
[2] Organic Letters, 2000, vol. 2, # 22, p. 3421 - 3423
  • 33
  • [ 99-11-6 ]
  • [ 853029-93-3 ]
Reference: [1] Organic and Biomolecular Chemistry, 2005, vol. 3, # 8, p. 1460 - 1467
[2] Patent: WO2012/45803, 2012, A1,
[3] Journal of Medicinal Chemistry, 2013, vol. 56, # 12, p. 5079 - 5093
  • 34
  • [ 99-11-6 ]
  • [ 501907-61-5 ]
Reference: [1] Patent: WO2012/97479, 2012, A1,
[2] Patent: WO2012/97682, 2012, A1,
[3] Patent: WO2012/97683, 2012, A1,
[4] Patent: US2014/171429, 2014, A1,
  • 35
  • [ 99-11-6 ]
  • [ 75-65-0 ]
  • [ 75308-46-2 ]
Reference: [1] Synthesis, 2008, # 17, p. 2764 - 2770
  • 36
  • [ 99-11-6 ]
  • [ 1390656-66-2 ]
Reference: [1] Patent: WO2012/97682, 2012, A1,
  • 37
  • [ 99-11-6 ]
  • [ 1196152-34-7 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 2, p. 231 - 240
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 99-11-6 ]

Carboxylic Acids

Chemical Structure| N/A

[ N/A ]

2-Oxo-1,2-dihydropyridine-4-carboxylic acid

Similarity: 0.83

Chemical Structure| 1123169-39-0

[ 1123169-39-0 ]

1-Ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid

Similarity: 0.80

Chemical Structure| 33972-97-3

[ 33972-97-3 ]

1-Methyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid

Similarity: 0.79

Chemical Structure| 556-08-1

[ 556-08-1 ]

4-Acetamidobenzoic acid

Similarity: 0.74

Chemical Structure| 5006-66-6

[ 5006-66-6 ]

6-Oxo-1,6-dihydropyridine-3-carboxylic acid

Similarity: 0.73

Related Parent Nucleus of
[ 99-11-6 ]

Pyridines

Chemical Structure| N/A

[ N/A ]

2-Oxo-1,2-dihydropyridine-4-carboxylic acid

Similarity: 0.83

Chemical Structure| 1123169-39-0

[ 1123169-39-0 ]

1-Ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid

Similarity: 0.80

Chemical Structure| 89937-77-9

[ 89937-77-9 ]

Methyl 1,2-dihydro-2-oxopyridine-4-carboxylate

Similarity: 0.80

Chemical Structure| 33972-97-3

[ 33972-97-3 ]

1-Methyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid

Similarity: 0.79

Chemical Structure| 5006-66-6

[ 5006-66-6 ]

6-Oxo-1,6-dihydropyridine-3-carboxylic acid

Similarity: 0.73